Moolec Science将合并2026年1月15比1的股份, Moolec Science will consolidate shares 15-to-1 in Jan 2026 to meet Nasdaq’s minimum price rule.

Moolec Science SA(NASDAQ:MLEC)宣布从2026年1月5日起合并15对1的股份,将未清股份从大约1 090万减少到726 000。 Moolec Science SA (NASDAQ: MLEC) announced a 15-for-1 share consolidation effective January 5, 2026, reducing outstanding shares from about 10.9 million to 726,000. 股东每15个旧股将获得1个新股,没有分期发行的股份——任何分期发行的股份都将得到1个新股。 Shareholders will receive one new share for every 15 old shares, with no fractional shares issued—any fractions rounded up. 新的股票价值为1.5美元,将在CUSIP G6223S125下在Nasdaq资本市场上进行交易。 The new shares, with a $1.50 par value, will trade on the Nasdaq Capital Market under CUSIP G6223S125. 搬迁的目的是帮助该公司重新遵守Nasdaq的1美元最低投标价格要求。 The move aims to help the company regain compliance with Nasdaq’s $1.00 minimum bid price requirement. 该公司利用分子农业和精密发酵生产可持续的食品成分,在美国、欧洲和南美洲开展业务,拥有118个专利。 The company, which uses molecular farming and precision fermentation to produce sustainable food ingredients, operates in the U.S., Europe, and South America and holds over 118 patents. 大陆股票转让和信托公司是转移代理人。 Continental Stock Transfer & Trust Company is the transfer agent. 前瞻性说明可能存在风险,包括市场条件和监管变化。 Forward-looking statements are subject to risks including market conditions and regulatory changes.